BSE Live
Oct 31, 16:01Prev. Close
50.11
Open Price
51.51
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Balance Sheet of Pharmaids Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 35.27 | 35.27 | 21.44 | 10.27 | 10.27 | |
| Total Share Capital | 35.27 | 35.27 | 21.44 | 10.27 | 10.27 | |
| Reserves and Surplus | 28.52 | 35.79 | 0.63 | -1.60 | -1.74 | |
| Total Reserves and Surplus | 28.52 | 35.79 | 0.63 | -1.60 | -1.74 | |
| Total Shareholders Funds | 63.79 | 71.06 | 22.43 | 8.67 | 8.53 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 39.40 | 12.50 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Long Term Liabilities | 0.16 | 0.28 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.11 | 0.06 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 39.67 | 12.84 | 0.00 | 0.00 | 0.00 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade Payables | 11.38 | 0.00 | 1.88 | 2.31 | 0.50 | |
| Other Current Liabilities | 3.85 | 1.10 | 0.24 | 0.13 | 0.09 | |
| Short Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Current Liabilities | 15.23 | 1.10 | 2.13 | 2.44 | 0.59 | |
| Total Capital And Liabilities | 118.69 | 85.00 | 24.55 | 11.11 | 9.12 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 24.18 | 16.55 | 0.11 | 0.03 | 0.04 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 3.51 | 2.30 | 2.00 | 0.45 | 0.45 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 27.69 | 18.85 | 2.11 | 0.48 | 0.49 | |
| Non-Current Investments | 52.61 | 52.60 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Assets [Net] | 5.15 | 3.84 | 2.71 | 0.36 | 0.35 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 1.47 | 6.19 | 6.66 | |
| Other Non-Current Assets | 20.56 | 4.95 | 0.79 | 1.42 | 0.76 | |
| Total Non-Current Assets | 106.01 | 80.24 | 7.07 | 8.44 | 8.26 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 3.27 | 0.00 | 0.00 | |
| Inventories | 9.77 | 0.23 | 0.00 | 0.89 | 0.37 | |
| Trade Receivables | 0.16 | 0.00 | 1.39 | 1.34 | 0.28 | |
| Cash And Cash Equivalents | 0.47 | 2.46 | 12.75 | 0.41 | 0.20 | |
| Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| OtherCurrentAssets | 2.29 | 2.07 | 0.07 | 0.03 | 0.01 | |
| Total Current Assets | 12.68 | 4.76 | 17.48 | 2.67 | 0.86 | |
| Total Assets | 118.69 | 85.00 | 24.55 | 11.11 | 9.12 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | -- | -- | -- | -- | -- | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
22.08.2025
Pharmaids Pharm Standalone June 2025 Net Sales at Rs 1.12 crore, up 569.85% Y-o-Y
27.05.2025
Pharmaids Pharm Standalone March 2025 Net Sales at Rs 0.13 crore, up 1792.86% Y-o-Y
04.03.2025
Pharmaids Pharm Consolidated December 2024 Net Sales at Rs 4.71 crore, up 22595.42% Y-o-Y
23.05.2022
Pharmaids Pharm Standalone March 2022 Net Sales at Rs 0.30 crore, down 83.95% Y-o-Y